Bolt Biotherapeutics Inc (BOLT) Stock: A 52-Week Tale of Drops and Gains

ZM Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Bolt Biotherapeutics Inc’s current trading price is -56.89% away from its 52-week high, while its distance from the 52-week low is 4.18%. The stock’s price range during this period has varied between $0.84 and $2.03. The company, active in the Healthcare sector, saw a trading volume of around 2.83 million for the day, considerably higher average daily volume of 0.14 million observed over the last three months.

Bolt Biotherapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $2.03 on 05/23/23, with the lowest value being $0.84 on 12/01/23.

How Financial Performance Impacts Market Capitalization

Bolt Biotherapeutics Inc (BOLT) has experienced a quarterly decline of -20.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 33.37M and boasts a workforce of 100 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1618, with a change in price of -0.1349. Similarly, Bolt Biotherapeutics Inc recorded 152,791 in trading volume during the last 100 days, posting a change of -13.36%.

How BOLT’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for BOLT stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.16.

BOLT Stock Stochastic Average

As of today, the raw stochastic average of Bolt Biotherapeutics Inc over the past 50 days is 3.97%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 5.80%. Additionally, the Stochastic %K and %D values for the company were 66.41% and 79.86%, respectively, over the past 20 days.

BOLT Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -21.87% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -10.70%. Over the past 30 days, the price of BOLT has leaped by -23.90%. And in the last five days, it has fallen by -21.16%.

Most Popular